Clinical trial
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients: Enhancing Technological Innovation and Strengthening the Role of Small Businesses in Meeting Needs of Adolescent Organ Transplant
NCT05732779 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients: Enhancing Technological Innovation and Strengthening the Role of Small Businesses in Meeting Needs of Adolescent Organ Transplant
- Lead sponsor
- University of Florida
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 1, 2024
- Completion date
- May 1, 2027
- Enrollment
- 100 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
health behavior, heart transplant rejection, immune suppression, medication nonadherence, patient engagement, pediatric heart transplant, remote monitoring